IVD Medical Holding seeks dual NASDAQ listing for American Depositary Shares

IVD Medical Holding Limited announced on September 30, 2025, its confidential submission of a draft F-1 registration statement to the United States Securities and Exchange Commission (SEC) on September 29, 2025. This filing is in connection with a proposed dual primary listing on the NASDAQ Stock Market in the United States, which will involve an initial public offering of American Depositary Shares (ADS) representing new ordinary shares.

The company anticipates the dual listing will expand global financing channels, enhance international brand influence, and improve share liquidity and valuation potential. It also expects to optimize corporate governance and transparency, while providing flexibility for future strategic advancements. The actual number of ADS to be offered, shares represented, and pricing are yet to be determined, pending market conditions and SEC review.

Shareholders and potential investors are advised to exercise caution as the proposed offering may or may not proceed.